Inaqovi Uniunea Europeană - română - EMA (European Medicines Agency)

inaqovi

otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - leucemie mieloidă - agenți antineoplazici - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.